Michael Baden

Michael Baden, a prominent forensic pathologist, joined the review of deaths at Memorial and LifeCare as the experts tried to determine what the available evidence could establish. He stood against the conclusion that decomposition made the cases medically unknowable: although drug concentrations in postmortem tissue were difficult to interpret, he emphasized that morphine and Versed had been found in patients who died without another competing cause of death. His assessments helped shape a consequential distinction between uncertainty about the exact dose and the possibility that drugs had contributed to deaths.

Role in the investigation

About a month after the arrests, Virginia Rider picked Baden up at the airport for a three-day meeting with Orleans Parish coroner Frank Minyard and Cyril Wecht. Minyard had invited Baden as well as Wecht, whose reputation was clouded by pending federal public-corruption charges. The review concerned how to classify suspicious deaths at Memorial and LifeCare. Minyard had kept many death certificates marked pending investigation, and District Attorney Eddie Jordan wanted the coroner’s classifications before taking possible indictments to a grand jury.

The experts met in the vacant Good Citizens Rhodes Funeral Home, where Minyard had set up temporary quarters because his offices in the criminal courts building remained damaged. Rider and two nurses prepared charts showing drugs found in the bodies, and Robert Middleberg, director of the Pennsylvania laboratory that had tested the samples, presented the results. Of forty-one bodies from Memorial and LifeCare analyzed by the laboratory, twenty-three tested positive for morphine, midazolam, or both. Baden entered a review in which laboratory findings had to be weighed against medical records and the circumstances of each patient’s death.

Findings on the seventh floor

The group considered each case rather than treating a positive toxicology result as self-explanatory. Among them was Alice Hutzler, a ninety-year-old LifeCare resident being treated for pneumonia. Her liver, brain, and muscle tissue contained morphine and midazolam, although her chart did not show either drug prescribed; records current until a few hours before her death recorded no recent complaint that indicated a need for them. Hutzler had been seen alive on the morning of September 1, as had the other eight LifeCare patients found on the seventh floor with one or both drugs in their systems. Memorial’s pathologist recorded all nine as dead that afternoon.

Wecht classified Hutzler’s death and seven of the other eight seventh-floor deaths as homicides, marking Elaine Nelson’s death undetermined because her records indicated that she was close to death that morning. Baden went further: he considered all nine deaths homicides. That difference matters. The experts were not merely sorting positive tests into a single conclusion; they were judging how each patient’s condition, records, and detected drugs bore on cause and manner of death. Baden’s assessment was the most categorical of the classifications reported for this group.

The broader pattern also informed the debate. At the meeting, nearly every tested patient who died after helicopters and boats arrived on Thursday morning was positive for the drugs. This included all nine patients on the LifeCare floor, nine patients in the second-floor lobby, and Merle Lagasse. Baden and the other experts saw the concentration of positive results among patients who had been alive that morning as a pattern requiring explanation, even as the meaning of any individual result remained a matter for case-by-case review.

Dispute over postmortem evidence

The central complication was that the bodies had remained in the heat for days before recovery. Postmortem tissue concentrations could not be read as straightforwardly as blood results from a living patient, and the group considered whether drugs had been given in a large dose shortly before death or accumulated through repeated administration. Medical conditions such as kidney or liver failure could affect how a patient processed medication; the experts also considered the effects of the drug combination on breathing and blood pressure and whether those effects fit the known timing of death.

Baden argued that uncertainty about the precise dose did not eliminate the significance of the drugs’ presence. He told Minyard that the patients had received Versed and morphine shortly before death and that there was no other competing cause of death. His position did not make postmortem toxicology equivalent to a direct observation of administration, but it resisted treating the difficulty of reconstructing exact concentrations as a reason to dismiss the evidence altogether.

Steven Karch, whom Minyard consulted later, argued that drug levels in a cadaver might bear no relationship to levels before death and advised leaving the medical causes undetermined. Minyard appeared persuaded by Karch’s position. Baden considered the argument beside the fact that drugs had been detected and the absence of another competing cause. Wecht separately challenged the theory by testing samples from overdose deaths after exposing them to hot, humid conditions; he found no significant difference from refrigerated samples. That small, unpublished study was not definitive, but it added another point of dispute rather than resolving the scientific uncertainty.

Prosecutors, public interpretation, and significance

The prosecutors’ reception of the experts’ work was cool. Michael Morales and Craig Famularo attended on the meeting’s second day and left after about half an hour. Their skeptical, uninterested manner struck Rider and the forensic pathologists as unusually hostile. Afterward, Baden remarked to Minyard that the prosecutors seemed unwilling to act. The contrast placed Baden’s medical assessment inside a larger institutional conflict: the experts were classifying deaths, while prosecutors had to decide what evidence could support a case before a grand jury.

Baden’s authority also reached the jury room through television. One juror was a devotee of his documentary series Autopsy and believed the experts’ reports that deaths at Memorial were homicides. She remembered Emmett Everett alive at breakfast on the Thursday morning, asking staff when they were going to rock and roll, and was struck by how many patients alive that morning had died by afternoon. Yet the juror also believed the case lacked testimony from someone who had seen Anna Pou inject a patient. Her conviction that a crime had occurred therefore did not remove the question of whether the evidence tied the charged deaths to the person named in the indictment.

Baden’s role was neither that of an investigator who witnessed the events nor that of a prosecutor deciding legal responsibility. He supplied expert judgments about cause and manner of death amid damaged records, delayed recovery, and disagreement over how much postmortem toxicology could prove. His categorical conclusion about the nine seventh-floor deaths, and his insistence that drug detection remained meaningful despite uncertainty about concentration, made him a central voice in the medical interpretation of the case. The later grand-jury dispute showed the limits of that authority: expert conclusions could persuade a juror that homicides had occurred without, by themselves, settling who had administered drugs or whether criminal charges could be proved.